News • Jan 17, 2019 15:09 GMT
Uppsala BIO and the real estate company Klövern have signed a three-year collaboration agreement for the further development of Uppsala Business Park located in Fyrislund, the city’s southernmost industry district. The ambition is to create a new business district for innovation and growth as part of a world-leading life science region.
National coordination and clearer rules for smoother introduction of digital tools into Swedish healthcare
News • Nov 08, 2018 09:23 GMT
Uppsala BIO was part of initiating a pilot study in 2016, which in 2017 led to Ordnat införande av digitala produkter och tjänster (ordered introduction of digital products and services), a collaborative effort led by SKL (Sveriges Kommuner och Landsting/ Swedish Association of Local Authorities and Regions) together with Region Norrbotten, Stockholm Science City and Uppsala BIO.
News • Aug 23, 2018 11:26 GMT
On 21 August, Testa Center – Sweden’s national test environment for verifying biological and technological tools used in manufacturing biologics or biopharmaceuticals – was officially inaugurated. And the first projects are ready to move in and get going!
News • Aug 23, 2018 11:14 GMT
This August, we see a new and exciting addition to Uppsala`s life science business sector. Based on research by Professor Gert Auer at Karolinska Institute, NeoProteomics AB started the development of biomarkers for sensitive and risk-free cancer diagnosis by analyzing platelets role in cancer.
News • Aug 21, 2018 14:12 GMT
Uppsala-based life science company Cavidi is an expert in HIV monitoring. Its first commercial product was a manual test for HIV monitoring in resource-limited settings, ExaVir Load. This product was an important step in taking care closer to the HIV-infected population in the parts of the world that are most affected.
News • Jun 14, 2018 12:48 GMT
Companies developing digital products also face a challenge: the demands made on their products and services are not always entirely clear. The question, therefore, is how can we simplify and improve the introduction of digital solutions?
News • May 24, 2018 08:56 GMT
Conextion, operational since its inauguration in January 2018, involves and gathers together a large number of life sciences employees, business consultants and representatives from the public support system. To see how we best can serve these interested parties, a number of activities have been tested.
Strong growth for Uppsala’s life science companies. Powerful force of attraction for other businesses.
News • Apr 26, 2018 11:12 GMT
It is very pleasing to note that Uppsala’s industrial development continues unabated. Our region is home to many prosperous and profitable businesses. Together with the universities, hospitals and national authorities in the region, they exert a powerful force of attraction that can draw other companies to Uppsala, writes Erik Forsberg, Managing Director at Uppsala BIO.
News • Apr 26, 2018 10:54 GMT
We at Uppsala BIO congratulate Kontigo Care, this week recognised with the eHealth Award 2018! The Uppsala-based company has developed Previct, a digital e-health platform that uses advanced AI (Artificial Intelligence) to enable patient diagnosis, care and aftercare.
News • Apr 26, 2018 08:20 GMT
That UIC is a key player in the business incubator world is well known. Now it has received Vinnova funding to carry out a pilot project aimed at developing a Swedish national platform for cutting-edge expertise in early-stage life science companies. Magnus Engevik, who works with business development at Uppsala BIO, has talked about the initiative with representatives of Vinnova and UIC.
News • Apr 26, 2018 07:12 GMT
How can novel technologies be used to create new and more effective treatments, promote health, improve patient experiences and reduce healthcare costs? During 2017 to 2019, Uppsala BIO is participating in a working group looking closely at the opportunities and challenges of introducing new digital technologies in healthcare.
News • Apr 18, 2018 12:00 GMT
Since its beginnings almost 10 years ago, Innovation Akademiska has assessed around 250 ideas, supported the formation of more than 20 companies and helped launch about 30 new products. And lots of good things are still happening right now! Magnus Engevik, Business Developer at Uppsala BIO, recently met Dr. Johan Kaarme, Innovation Akademiska’s Executive Director, for an update of the situation.
News • Mar 19, 2018 14:52 GMT
Helena Dzojic, Head of Medical Devices at the Swedish Medical Products Agency (MPA), answers questions about new EU regulations in medical device sector.
Seeking contact with larger companies as part of your route to market? Know-how and financial support now available through ‘Industrial Partnerships’
News • Mar 16, 2018 13:21 GMT
In the life sciences, many small ventures with early-stage projects need to have a dialogue with larger companies as part of their business development process. The goal of such exchanges can be to gain industrial feedback on proposals/business ideas, to seek potential collaboration and funding, or to access large-company expertise and in-house resources, for example.
News • Feb 28, 2018 06:30 GMT
The life science industry is growing and the demand for a competent labour force in manufacturing is high. But it is difficult for companies to find employees with the right skills. A new type of education may be the answer, says Eva Nicklasson, who has investigated the matter.
News • Feb 27, 2018 10:12 GMT
The United Kingdom’s NHS (National Health Service) is actively investing in the digital revolution to enable patients and healthcare to benefit from the most useful products and services now presenting themselves. Its approach to a national process, the most progressive to be found today, may be a good model for us to follow in Sweden.
Press Releases • Feb 22, 2018 11:54 GMT
In November 2017, Uppsala BIO arranged a meeting to bring together life science companies seeking mid-sized investments and investors looking to make such placements. We are happy to announce a very positive outcome for two of the participants: Impilo is now investing US$ 11.5 million in Cavidi.
News • Feb 20, 2018 15:34 GMT
Kontigo showed that over the past ten years, share issues increased the influx of capital to companies in Uppsala’s life science sector by almost SEK 5 billion. Medical technology, including diagnostics, is the area that attracts the highest proportion of capital.
News • Jan 25, 2018 08:52 GMT
During December, representatives for the new Swedish test-bed infrastructure focused on biopharmaceutical manufacturing have been on tour to spread the word about what it is and whom it’s for. Now officially named Testa Center, it will open June 2018 at GE Healthcare’s Uppsala site.
News • Jan 23, 2018 16:18 GMT
Helena Ströberg and Magnus Engevik begin work in January as new business development and project managers at Uppsala BIO. Both have solid experience from the business world as well as innovation support organisations.